ARTG Inclusion vs Exemption: When Retailers Can Supply Without Registration

ARTG Inclusion

Inclusion of a therapeutic good in the Australian Register of Therapeutic Goods before legal supply in Australia unless an exemption or exclusion applies.

Retailers frequently ask whether a product must be on the ARTG or whether an exemption or other pathway allows lawful supply. The short answer: in most commercial supply situations a therapeutic good must be included on the ARTG, but legitimate exemptions and alternative schemes exist. Distinguishing inclusion from exemption requires understanding the product type, intended use, and the supply pathway.

Key Differences Between Inclusion And Exemption

Inclusion is a permanent public record that a product has met regulatory requirements for supply as a therapeutic good. An exemption or exclusion is a temporary or conditional exception where the product may be lawfully supplied without ARTG entry, subject to restrictions. Key differences include:

• Regulatory Status: Inclusion grants a formal regulatory status on the ARTG; an exemption does not confer that status and usually limits how widely the product can be supplied.
• Evidence Requirement: Inclusion generally requires formal evidence submissions (safety, quality, efficacy, or conformity assessment). Exemptions often have alternative documentation or procedural approvals (for a clinical trial, compassionate use, or personal import).
• Commercial Supply: Inclusion permits broader commercial sale and advertising (subject to other rules). Exempted supply is commonly narrow, controlled, or non‑commercial.

Common Exemption Pathways Relevant To Retailers

Retailers should be aware of several TGA pathways that allow supply without ARTG inclusion — none are automatic for commercial retailing:

• Clinical Investigational Use: Goods supplied for clinical trials under appropriate notifications or approvals are not entered on the ARTG while used as investigational products.
• Special Access & Authorised Prescriber Schemes: These pathways allow access to unapproved therapeutic goods for individual patients under clinical oversight; they are patient‑specific not general retail channels.
• Personal Importation: Individuals can import some therapeutic goods for personal use under limited conditions; a retailer importing and selling those goods commercially does not qualify for personal importation protections.
• Emergency Authorisations or Concessions: In defined public health emergencies or special circumstances, temporary concessions may be granted allowing supply prior to inclusion.

What Exemptions Mean For A Retailer’s Business Model

Relying on an exemption is rarely a viable long‑term commercial strategy. Exemptions are typically narrow in scope and require supporting records. If a retailer intends to sell a therapeutic good on a recurrent, commercial basis, the practical route is to ensure the product is on the ARTG or source products from a sponsor who has completed inclusion.

Red Flags And Compliance Traps

Retailers should avoid assumptions and watch for common compliance traps:

• Supplier Claims: Do not accept vague assurances that a product is “TGA‑approved” — request the ARTG number and verify it in the public register.
• Misuse Of Personal Importation: Sellers who import products and resell them are not protected by personal importation provisions; this can result in seizure and penalties.
• Advertising Mistakes: Even if a product is exempt from ARTG inclusion, certain advertising rules may still apply — check the specific exemption conditions.

How To Decide Whether A Product Needs Inclusion

When assessing a product, follow a practical decision path:

• Classify: Determine whether the product is a medicine, complementary medicine, or medical device under TGA definitions.
• Check ARTG: Search the ARTG database for the product, active ingredients, or sponsor details.
• Verify Pathways: If not on ARTG, investigate whether a legitimate exemption, special access route, or investigational status applies.
• Legal Advice: For ambiguous cases or high‑volume commercial supply, obtain regulatory or legal advice.

Practical Example: Nutritional Supplement Versus Medicine

A nutritional supplement marketed with general health language might be classified as a complementary medicine and listed on the ARTG. If a supplier markets the same product with disease‑treatment claims the product could be classified as a medicine needing full registration. The classification determines whether inclusion or an exemption might apply; retailers must treat these label and claim differences as determinative for ARTG requirements.

In short, the ARTG Inclusion requirement is the default path to lawful commercial supply of therapeutic goods in Australia. Exemptions exist but are narrow and conditional — retailers should confirm ARTG status before listing products and avoid relying on exemptions unless explicitly applicable and documented.